• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白杨素与高压氧疗法改善慢性肾脏病动物模型的肾功能和结构。

Apocynin and Hyperbaric Oxygen Therapy Improve Renal Function and Structure in an Animal Model of CKD.

作者信息

Vukovic Andrija, Karanovic Danijela, Mihailovic-Stanojevic Nevena D, Miloradovic Zoran, Brkic Predrag, Zivotic Maja, Nesovic Ostojic Jelena, Ivanov Milan, Kovacevic Sanjin, Vajic Una-Jovana, Jovovic Djurdjica, De Luka Silvio R

机构信息

Institute of Pathological Physiology, Faculty of Medicine, University of Belgrade, Dr Subotića 1, 11000 Belgrade, Serbia.

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr Subotića 4, 11000 Belgrade, Serbia.

出版信息

Biomedicines. 2024 Dec 9;12(12):2788. doi: 10.3390/biomedicines12122788.

DOI:10.3390/biomedicines12122788
PMID:39767695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11673868/
Abstract

BACKGROUND/OBJECTIVES: Chronic kidney disease (CKD) is a progressive pathological condition which results in the severe fibrosis of the kidneys. However, the mechanisms of CKD progression and fibrogenesis remain unclear. We wanted to examine the effects that apocynin and hyperbaric oxygen therapy (HBOT) have on renal function and structure in animals with CKD induced through 5/6 nephrectomy (5/6 Nx-L).

METHODS

Male Wistar rats were divided in 5 groups (n = 8/group) as follows: control-sham-operated rats; Nx-L-rats with 5/6 Nx-L; APO-5/6 Nx-L + apocynin treatment; HBOT-5/6 Nx-L + hyperbaric oxygen treatment, and APO+HBOT-5/6 Nx-L, treated with both treatments. All treatments started 4 weeks after the final step of CKD induction and lasted for 4 weeks. At the end of the experiment, urine samples were collected for the proteinuria assessment and the mean arterial pressure (MAP) was measured. Kidneys were collected for histopathological, Western blot, and immunohistochemical analyses.

RESULTS

All treatments significantly decreased MAP compared to the Nx-L group ( < 0.001). In the APO and APO+HBOT groups, the level of proteinuria was decreased compared to the Nx-L group ( < 0.05 and < 0.01, respectively). All examined treatments significantly decreased the intensity of lesions in the kidney compared to those observed in the Nx-L group ( < 0.001). Isolated treatments with apocynin and HBOT induced a significant decrease in desmin expression compared to the Nx-L group ( < 0.05); meanwhile, they did not affect the levels of fibronectin (FN) and hypoxia-inducible factor-1α (HIF-1α). Combined treatment did not affect desmin expression levels; however, it induced a significant increase in fibronectin expression compared to Nx-L ( < 0.001).

CONCLUSIONS

Apocynin treatment decreased BP and protein loss, and it improved renal morphology at least partly through the downregulation of desmin expression without changing FN and HIF-1α. Hyperbaric oxygen therapy improved hypertension but failed to significantly affect the level of proteinuria. Combined treatment (apocynin and HBOT) normalized blood pressure (BP) values, renal function, and improved kidney structure by modulating FN and HIF-1α, without affecting desmin protein expression. Further studies are needed to elucidate the mechanisms of slowing down the progression of CKD in this experimental model.

摘要

背景/目的:慢性肾脏病(CKD)是一种进行性病理状态,可导致肾脏严重纤维化。然而,CKD进展和纤维化形成的机制仍不清楚。我们想研究阿朴吗啡和高压氧疗法(HBOT)对通过5/6肾切除术(5/6 Nx-L)诱导的CKD动物的肾功能和结构的影响。

方法

将雄性Wistar大鼠分为5组(每组n = 8),如下:假手术对照组大鼠;5/6 Nx-L诱导的CKD大鼠;APO-5/6 Nx-L + 阿朴吗啡治疗组;HBOT-5/6 Nx-L + 高压氧治疗组,以及APO+HBOT-5/6 Nx-L组,接受两种治疗。所有治疗在CKD诱导最后一步后4周开始,持续4周。实验结束时,收集尿液样本进行蛋白尿评估,并测量平均动脉压(MAP)。收集肾脏进行组织病理学、蛋白质印迹和免疫组织化学分析。

结果

与Nx-L组相比,所有治疗均显著降低了MAP(< 0.001)。在APO和APO+HBOT组中,与Nx-L组相比,蛋白尿水平降低(分别为 < = 0.05和 < = 0.01)。与Nx-L组相比,所有检查的治疗均显著降低了肾脏病变的严重程度(< 0.001)。与Nx-L组相比,单独使用阿朴吗啡和HBOT治疗可显著降低结蛋白表达( < 0.05);同时,它们不影响纤连蛋白(FN)和缺氧诱导因子-1α(HIF-1α)的水平。联合治疗不影响结蛋白表达水平;然而,与Nx-L组相比,它诱导纤连蛋白表达显著增加(< 0.001)。

结论

阿朴吗啡治疗可降低血压和蛋白质丢失,并至少部分通过下调结蛋白表达改善肾脏形态,而不改变FN和HIF-1α。高压氧疗法可改善高血压,但未能显著影响蛋白尿水平。联合治疗(阿朴吗啡和HBOT)通过调节FN和HIF-1α使血压(BP)值、肾功能正常化,并改善肾脏结构,而不影响结蛋白的表达。需要进一步研究以阐明在该实验模型中减缓CKD进展的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/35154cf69ff4/biomedicines-12-02788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/2a4a6ccd53e1/biomedicines-12-02788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/d5700c41dba6/biomedicines-12-02788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/efb9cfcf432d/biomedicines-12-02788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/35154cf69ff4/biomedicines-12-02788-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/2a4a6ccd53e1/biomedicines-12-02788-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/d5700c41dba6/biomedicines-12-02788-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/efb9cfcf432d/biomedicines-12-02788-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4619/11673868/35154cf69ff4/biomedicines-12-02788-g004.jpg

相似文献

1
Apocynin and Hyperbaric Oxygen Therapy Improve Renal Function and Structure in an Animal Model of CKD.白杨素与高压氧疗法改善慢性肾脏病动物模型的肾功能和结构。
Biomedicines. 2024 Dec 9;12(12):2788. doi: 10.3390/biomedicines12122788.
2
A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.黄芪和当归这两种中药的组合改善了5/6肾切除大鼠的肾微血管功能不全。
Vascul Pharmacol. 2009 May-Jun;50(5-6):185-93. doi: 10.1016/j.vph.2009.01.005.
3
Early hyperbaric oxygen therapy through regulating the HIF-1α signaling pathway attenuates Neuroinflammation and behavioral deficits in a mouse model of Sepsis-associated encephalopathy.早期高压氧治疗通过调节 HIF-1α 信号通路减轻脓毒症相关性脑病小鼠模型的神经炎症和行为缺陷。
J Neuroimmunol. 2024 Jun 15;391:578367. doi: 10.1016/j.jneuroim.2024.578367. Epub 2024 May 7.
4
Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.补充酮酸的低蛋白饮食通过直接抑制肾内肾素-血管紧张素系统改善3/4肾切除大鼠的蛋白尿。
Br J Nutr. 2016 Nov;116(9):1491-1501. doi: 10.1017/S0007114516003536. Epub 2016 Oct 18.
5
Hyperbaric Oxygen Therapy Attenuates Burn-Induced Denervated Muscle Atrophy.高压氧疗法可减轻烧伤所致失神经肌肉萎缩。
Int J Med Sci. 2021 Oct 25;18(16):3821-3830. doi: 10.7150/ijms.65976. eCollection 2021.
6
Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.洛沙坦-氢氯噻嗪联合治疗在晚期肾病模型中对蛋白尿和高血压的消退及严重肾脏损伤的抑制作用。
PLoS One. 2013;8(2):e56215. doi: 10.1371/journal.pone.0056215. Epub 2013 Feb 19.
7
Netrin-1 attenuates the progression of renal dysfunction by inhibiting peritubular capillary loss and hypoxia in 5/6 nephrectomized rats.Netrin-1 通过抑制 5/6 肾切除大鼠肾小管周毛细血管丢失和缺氧来减轻肾功能障碍的进展。
Kidney Blood Press Res. 2012;36(1):209-19. doi: 10.1159/000343410. Epub 2012 Nov 12.
8
Effect of NADPH oxidase inhibitor apocynin on the expression of hypoxia-induced factor-1α and endothelin-1 in rat carotid body exposed to chronic intermittent hypoxia.NADPH氧化酶抑制剂白杨素对慢性间歇性低氧大鼠颈动脉体中缺氧诱导因子-1α和内皮素-1表达的影响
J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):178-184. doi: 10.1007/s11596-013-1093-z. Epub 2013 Apr 17.
9
Effect of Hyperbaric oxygen on myelin injury and repair after hypoxic-ischemic brain damage in adult rat.高压氧对成年大鼠缺氧缺血性脑损伤后髓鞘损伤及修复的影响
Neurosci Lett. 2023 Jan 18;794:137015. doi: 10.1016/j.neulet.2022.137015. Epub 2022 Dec 13.
10
Study on HIF-PHI combined with iron supplement in treatment of renal anemia in rats.低氧诱导因子脯氨酰羟化酶抑制剂联合铁剂治疗大鼠肾性贫血的研究
BMC Nephrol. 2025 Mar 6;26(1):125. doi: 10.1186/s12882-025-04045-y.

引用本文的文献

1
Electroanalysis of Apocynin Part 2: Investigations on a Boron-Doped Diamond Electrode in Aqueous Buffered Solutions.阿朴啡的电分析 第2部分:在水性缓冲溶液中硼掺杂金刚石电极上的研究
Materials (Basel). 2025 Apr 29;18(9):2044. doi: 10.3390/ma18092044.

本文引用的文献

1
Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study.高压氧治疗的新适应症:登记队列研究
Interact J Med Res. 2024 Aug 20;13:e53821. doi: 10.2196/53821.
2
Linking renal hypoxia and oxidative stress in chronic kidney disease: Based on clinical subjects and animal models.将慢性肾脏病中的肾缺氧与氧化应激联系起来:基于临床研究和动物模型。
Biomol Biomed. 2024 Sep 6;24(5):1319-1330. doi: 10.17305/bb.2024.10257.
3
Tubular toxicity of proteinuria and the progression of chronic kidney disease.蛋白尿的管状毒性与慢性肾病的进展。
Nephrol Dial Transplant. 2024 Mar 27;39(4):589-599. doi: 10.1093/ndt/gfad215.
4
Kidney fibrosis: Emerging diagnostic and therapeutic strategies.肾纤维化:新兴的诊断与治疗策略
Mol Aspects Med. 2023 Oct;93:101206. doi: 10.1016/j.mam.2023.101206. Epub 2023 Aug 3.
5
Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.慢性肾脏病中缺氧和缺氧诱导因子 asparaginyl 羟化酶调节的演变。
Nephrol Dial Transplant. 2023 Sep 29;38(10):2276-2288. doi: 10.1093/ndt/gfad075.
6
Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease.佩马贝特在腺嘌呤诱导的慢性肾病小鼠模型中抑制肾功能障碍和纤维化。
Life Sci. 2023 May 15;321:121590. doi: 10.1016/j.lfs.2023.121590. Epub 2023 Mar 20.
7
ZEB2 controls kidney stromal progenitor differentiation and inhibits abnormal myofibroblast expansion and kidney fibrosis.ZEB2 控制肾脏基质祖细胞分化,抑制异常肌成纤维细胞扩增和肾脏纤维化。
JCI Insight. 2023 Jan 10;8(1):e158418. doi: 10.1172/jci.insight.158418.
8
The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease.缺氧诱导因子-1α在肾脏疾病中的作用。
Molecules. 2022 Oct 28;27(21):7318. doi: 10.3390/molecules27217318.
9
Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress.组织蛋白酶 K 缺乏可预防慢性应激或不伴慢性应激的 5/6 肾切除损伤小鼠的肾脏损伤和功能障碍。
Hypertension. 2022 Aug;79(8):1713-1723. doi: 10.1161/HYPERTENSIONAHA.122.19137. Epub 2022 Jun 21.
10
Comparison of the surgical resection and infarct 5/6 nephrectomy rat models of chronic kidney disease.慢性肾脏病手术切除和梗死 5/6 肾切除术大鼠模型的比较。
Am J Physiol Renal Physiol. 2022 Jun 1;322(6):F639-F654. doi: 10.1152/ajprenal.00398.2021. Epub 2022 Apr 4.